AGP Executive Report

Medicare GLP-1 Shift: A new CMS pilot (“Medicare GLP-1 Bridge”) starts July 1, letting eligible older adults get weight-loss GLP-1s for a flat $50/month through Dec. 31, 2027—an overdue change for patients long shut out of coverage, though questions remain about how the short-term program will end. Maternal Care Expansion: Wisconsin expands postpartum Medicaid coverage to 12 months, expected to help 16,000+ new mothers, including mental health and opioid use disorder treatment. Access Under Pressure: Ghana’s Odawna CHPS compound is appealing for urgent help after floods destroyed equipment and patient records, disrupting care for thousands. Rare-Disease Pharma Deal: SERB Pharmaceuticals completes acquisition of EU/UK/MENA rights to Idefirix (imlifidase) from Hansa Biopharma, aiming to expand access for transplant-related needs. Device Cybersecurity Standard: SGS awards Yaoshi the first IEC 81001-5-1 CB certification for medical device cybersecurity, signaling tighter global compliance expectations. Healthcare System Stress: England faces growing “pharmacy deserts,” with 500+ closures since 2022, worsening access as prescription volumes rise.

Medicare Fraud Crackdown: A telemedicine owner and nurse practitioner, Jean Wilson, was sentenced to 10 years and ordered to pay $66M in restitution for a $136M Medicare scheme involving kickbacks for unnecessary braces and drugs. Medicaid Under Pressure: HHS suspended funding for New York’s Medicaid Fraud Control Unit, citing weak performance, while Wisconsin reported a Medicaid data exposure affecting 8,157 SSI recipients due to mail sent to old addresses. Policy Fight Over Coverage: 25 Democratic-led states sued the Trump administration over tightened “medically frail” rules that could force ill and disabled people off Medicaid. FDA Manufacturing Push: FDA named seven companies for its PreCheck Pilot Program to speed earlier engagement for new U.S. drug manufacturing facilities. GLP-1 Access: Medicare begins covering weight-loss GLP-1s for some beneficiaries via a limited $50 program starting July 1, with concerns about short-term chaos for prescribers. Rural Access: A rural pharmacy desert initiative in Minnesota uses home-delivery tech plus pharmacy infrastructure to bring 24/7 support into patients’ homes. Clinical Pipeline: Mesoblast received an FDA BLA filing number and requested modular review for rexlemestrocel-L in end-stage heart failure patients with LVADs.

Medicare GLP-1 Shift: Medicare is launching a temporary “GLP-1 Bridge” pilot starting July 1, letting eligible beneficiaries access weight-loss drugs like Zepbound and Wegovy with a $50-a-month co-pay, but with prior authorization and a planned end by Dec. 31, 2027. Medicaid Work Requirements Fallout: States and health centers are bracing for major Medicaid changes tied to new work rules, with experts warning of coverage losses, more uninsured patients, and system-wide cost pressure. Cancer & Rare Disease Pipeline: FDA authorized use of the clonoSEQ MRD test in Imviva’s TENACITY-01 CAR-T trial; Monopar received Rare Pediatric Disease designation for ALXN1840 in Wilson disease; and Quoin won a key patent notice for a Netherton syndrome combination therapy. Pain & Delivery Tech: Dogwood added a scientific advisory board chair to advance non-opioid pain programs, while Microbot expanded manufacturing capacity for its LIBERTY robotic system via Sanmina. Healthcare Access & Ops: Ally Medical opened an ER in Cedar Park, and Nebraska Medicine’s governance transition begins July 1 with equal voting representation during a temporary period. Pharma Integrity Watch: NEJM retracted an Amgen Tavneos paper after FDA-linked concerns about trial data handling.

Access to Cholesterol Care: New Zealand’s Pharmac will widen access to rosuvastatin by removing eligibility criteria from 1 Oct 2026, letting clinicians prescribe based on clinical need. Medicaid Fight: New Jersey and other Democratic-led states sue the Trump administration over new Medicaid work rules, arguing “medically frail” exemptions are too narrow and could strip coverage from vulnerable people. Fraud Crackdown: Texas reaches a nearly $34M AstraZeneca settlement over alleged Medicaid kickbacks tied to provider incentives to push prescriptions. Health System Governance: Nebraska Medicine’s buyout is approved by the University of Nebraska Board of Regents, with Omaha Community Foundation stepping in temporarily to oversee governance. New Treatment/Products: FDA approves Arcutis’ ZORYVE (roflumilast) cream 0.3% for plaque psoriasis in children as young as age 2. Behavioral Health Expansion: Serenus Outpatient Detox opens in Jacksonville, offering medically supervised outpatient withdrawal care. Workforce & Training: NZDF medics graduate from a joint NZDF-AUT program at Burnham, expanding pre-hospital emergency training capacity. Medical Debt Relief: A coalition plans to wipe out $170M in medical debt for more than 140,000 low- and middle-income residents in Eastern Massachusetts.

Occupational Health in Qatar: Qatar’s Ministry of Municipality opened a new clinic at the General Cleanliness Department Complex, offering screening, primary care, and medication dispensing for 3,200 workers across two daily shifts. Pediatric Allergy Care in Qatar: Hamad Medical Corporation launched specialized pediatric allergy testing, including skin testing and supervised food/drug challenge tests, to improve early diagnosis and reduce complications. Heart Failure Access in Canada: A new Canadian Journal of Cardiology study models pharmacist- and nurse practitioner-led medication management for HFrEF, projecting longer survival, fewer hospital days, and better cost-effectiveness. Medicare Advantage Prior Authorization: The American Medical Association backed a U.S. House push to cut administrative delays in Medicare Advantage by reforming prior authorization. Obesity Drug Matching: A pilot study suggests a simple fasting blood test measuring GLP-1 and GIP could help predict which patients respond best to semaglutide or tirzepatide. Drug Safety Recall (U.S.): Amgen recalled about 944,000 bottles of Corlanor and Sensipar after foreign material was found on tablet coatings; FDA says risk is low. Regulatory Setbacks (EU): EMA’s CHMP recommended refusing marketing authorization for three investigational cancer/transplant therapies due to an unestablished benefit-risk balance. Medical Education Policy (India): India is reviewing the NEET PG “zero-percentile” cut-off policy amid concerns about postgraduate training standards. Healthcare Workforce (Bahamas): The Bahamas is starting a feasibility study with UWI to establish a full medical school. Clinical Trial Expansion (Canada/Global): Health Canada approved expanding Biodexa’s Serenta Phase 3 trial in familial adenomatous polyposis into Canada, adding new recruiting centers.

Medical procurement scandal: India’s ACB arrested former DGHS chief Dr Vatsala Agarwal and former CPA deputy controller Neeraj Chopra over alleged inflated medical procurement bills, with “missing files” flagged and more officials reportedly in the probe. Regulation speed-up: India’s health ministry proposed faster licensing and auditing timelines for medical devices, aiming to simplify approvals for moderate- to high-risk products while keeping quality and safety checks. AI in radiology: Aidoc’s chest X-ray reporting tool won FDA Breakthrough Device designation, designed to draft radiology reports faster while keeping clinician oversight. Medicare fraud: DOJ announced charges tied to a large Medicare/Medicaid fraud takedown, including a nurse practitioner accused of $906M in hospice-related claims. Drug recalls: Amgen recalled nearly 1 million bottles of heart and kidney meds after foreign material was found on tablet surfaces. Access & safety: Canada issued a guideline urging annual medication reviews for seniors to curb overprescribing; experts also warned some common drugs can worsen heat risk by disrupting sweating and temperature control. Care delivery: Kansas City’s Carehouse medical respite facility is set for a $6M renovation to expand beds for people recovering from hospital discharge. Clinical research: A major international trial found cefazolin and benzylpenicillin may be safer alternatives to cloxacillin for staphylococcal bloodstream infections.

Medical Device Regulation (India): India’s health ministry has proposed cutting manufacturing-licence timelines under the Medical Devices Rules, 2017—reducing Class B from 140 to 115 days and Class C/D from 105 to 90 days—aiming to speed access while keeping quality and safety checks. Fake Medicines Crackdown (Nepal/Pakistan): Nepal intensified market surveillance after fake Seroflo Rotacaps 250 was found, while Pakistan’s DRAP set an Oct 9 deadline for mandatory 2D barcode track-and-trace to let people verify authenticity. FDA Oversight Pressure (US): A new FDA approach is criticized for weakening in-person inspection coverage, raising concerns about how well quality is independently verified. Recall Alert (US): Nearly 1 million bottles of heart and kidney drugs (Corlanor and Sensipar) were recalled after unexpected foreign matter was found on tablet surfaces. Medicare Alzheimer’s (US): A Medicare explainer says diagnosis and treatment are largely covered (Part B and often Part D for meds), but long-term custodial care is not. Healthcare Access (Nepal/Idaho/UK): Nepal’s Salyan patients face a three-month free-medicine shortage; Idaho lawmakers held a Medicaid cost town hall; and the UK moves toward banning plastic-containing wet wipes across all four nations. Humanitarian Response (Venezuela/India): Red Cross teams ramp up search and rescue after major earthquakes, while India’s Operation Amistad sent field hospitals and modular BHISHM cubes. Care Delivery (US): Baptist Health South Florida and Amazon One Medical announced a partnership to expand coordinated primary and specialty care.

Drug Safety: The FDA recalled 11,460 bottles of chlorthalidone tablets after they failed dissolution specs, raising concerns about reduced effectiveness. Digital Health Access: Namibia’s clinics still rely on long manual queues, and a push for digital ticketing and linked patient profiles aims to cut delays and improve medication access. New FDA Approval: Viridian Therapeutics’ Lumvoa (veligrotug-vvze) won US FDA approval for thyroid eye disease across both active and chronic stages, with immediate commercial availability. Medicaid Pressure: Kentucky Medicaid reimbursement cuts starting Aug. 1 are already worrying nonprofits like the Marshall County Exceptional Center, which relies on waivers for part of its budget. Healthcare Fraud Watch: Montana Senior Medicare Patrol is urging residents to review Medicare statements and watch for scams during Medicare Fraud Prevention Week. Global Relief: India launched Operation Amistad to support earthquake-hit northern Venezuela, sending a 41-member medical team, field hospital gear, medicines, and BHISHM Cubes. Patient Care Quality: MyMichigan Medical Center Sault was recognized for the lowest NTSV C-section rate in Michigan (12.4% vs 27.2% statewide). Rehab Workforce: Nigeria’s rehab board urged more funding and physiotherapy workforce expansion to improve access to rehabilitation services.

Medicaid Funding Pause: Colorado’s Sunshine Rides says it will temporarily pause disruptions and layoffs after a state review of Medicaid non-emergency medical transportation reimbursement reductions, with a decision expected by July 6. Health Policy & Access: Ohio Planned Parenthood will resume accepting Medicaid for preventive services after a federal reimbursement ban expires July 3. Fraud Crackdown: Federal prosecutors charged nine people in Florida in alleged Medicare/Medicaid/VA kickback and wound-care fraud schemes totaling millions. Drug Safety & Supply: Pakistan plans barcode tracking for every medicine within 60 days to curb counterfeits. Clinical Care & Research: Sidra Medicine launched a specialized Microbiome Service for women and children, supporting precision medicine and research. Public Health & Education: Kenya reported 53% growth in registered pharmaceutical premises since 2018, alongside workforce gains. Local Health Systems: A fire damaged parts of UDUS’s Hamidu Ahmed Medical Library complex, but the core collections were reported intact.

Medical Debt Relief: Snap CEO Evan Spiegel and Miranda Kerr’s donation to Undue Medical Debt will erase medical bills for 261,000+ Californians, totaling over $550M, with the biggest share in San Diego County. Rural Care Spotlight: Cuyuna Regional Medical Center in Minnesota was named to Becker’s “100 Critical Access Hospitals to Know,” citing growth in surgeries and plans for an oncology department and new clinic. Medicaid Fraud Crackdown: U.S. and state prosecutors announced five Medicaid fraud arrests in Arkansas as part of a national health care fraud takedown. Pediatric Mental Health Access: Alberta’s pediatric mental health system is being framed around a continuum of care and a single 2-1-1 access line, after a study flagged gaps. Cancer Research & Innovation: Researchers presented AI work characterizing muscle loss in advanced prostate cancer on systemic therapy. Humanitarian Response: India’s Operation Amistad is sending C-17s and a 41-person Army medical team to quake-hit Venezuela with field-hospital capability and medical supplies. Policy Pressure on Care: Kentucky providers warn Medicaid reimbursement cuts could force staffing cuts or closures, threatening waiver services. Drug Safety & Regulation: Malta Medicines Authority granted EU GMP certification to Indoco Remedies’ Goa plant after inspection.

Oligonucleotide Breakthroughs: Oligonucleotide therapies are expanding fast, with more than 20 approved and 700+ in development, and conjugation chemistry emerging as a key way to improve stability, delivery, and targeting. EU Disaster Response: The EU is mobilizing rescue teams and medical staff to support earthquake-hit Venezuela, including firefighters, rescue dogs, and satellite support. Diabetes Tech Rollout: Modular Medical says its Pivot tubeless insulin patch pump is now shipping to endocrinology practices for training, with phased expansion planned through late 2026. Drug Pricing Tensions: The Trump administration is probing Germany over “persistent underpayment” for U.S. medicines, escalating pressure on pricing and trade terms. Health Data Privacy: England’s NHS is investigating about 40 staff who accessed a boy’s medical records after a crocodile attack, with the trust referring the matter to the information watchdog. EMA Updates: The CHMP issued a mix of positive opinions and one major setback—recommending changes for multiple medicines (including Orladeyo, Rinvoq, and new biosimilars) while recommending revoking Tavneos after concerns about benefit-risk balance. Fraud Spotlight: A Glendale doctor was convicted for allegedly billing Medicare $45M for Botox claims that were never performed or justified.

Medicare Fraud Crackdown: A Vermont woman, Victoria Hall, was arraigned on felony identity theft and Medicaid fraud claims tied to alleged fake psychotherapy visits. Medicare Supply-Chain Fraud: A Stoughton man is set to plead guilty to allegedly defrauding Medicare of $5.1M+ via claims for orthotic braces patients didn’t need. Patient Access & Pricing: Walgreens says pharmacists will help eligible Medicare patients use the new CMS “GLP-1 Bridge” program starting July 1, with a $50 monthly copay for qualifying beneficiaries. Patient Safety vs Knockoffs: The Partnership for Safe Medicines calls for stronger enforcement to curb unapproved compounded GLP-1 knockoffs. Care in the Air: An Air Canada flight diverted to Boston after the captain’s medical emergency; passengers helped restrain the pilot. Clinical AI & Training: UND is exploring an AI hub to support rural healthcare, research partnerships, and student training. Tech for Clinicians: OpenEvidence and JOMI partnered to bring peer-reviewed surgical videos into AI retrieval for point-of-care learning. Policy Watch: Ohio’s hospital price transparency law is facing enforcement gaps, raising concerns about what patients actually see before care.

Medical Debt Relief: Michigan will erase $74 million in medical debt for 71,871 residents, building on prior rounds of relief as advocates push for affordability in care. PBM Scrutiny: Florida’s AG became the first to subpoena CVS’s secret contracts with drug makers and pharmacies, aiming to expose how PBMs drive up costs and squeeze access. Cancer & Care Delivery Tech: IIT Kanpur researchers mapped the C5aR2 immune receptor, a step toward safer medicines; and a new analysis finds patient portal messages have surged, raising clinician workload and burnout concerns. Drug Supply Chain Security: India expanded QR code track-and-trace rules to more drug categories, including vaccines, antimicrobials, narcotics/psychotropics, and anti-cancer medicines. Clinical Pipeline Moves: Vivani Medical got ethics approval to start a Phase 1 trial of a semaglutide implant in obesity; and Atea Pharmaceuticals completed enrollment in a global Phase 3 HCV trial with topline results expected by year-end. Access & Policy: West Virginia Medicaid is urging members to prepare for 2027 federal eligibility changes, while Illinois passed a law protecting abortion-related medical records from out-of-state sharing.

Cancer Screening Access: WVU Medicine’s mobile lung cancer screening unit, LUCAS, will bring low-dose CT scans to West Virginia sites in Weston, Rock Cave, and Buckhannon in mid-July, with options for Medicare/Medicaid/private insurance and grant support for eligible uninsured patients. Nuclear Medicine Accreditation: Hamad Medical Corporation in Qatar earned SNMMI recognition as a Radiopharmaceutical Therapy Centre of Excellence, expanding high-quality radiopharmaceutical therapy services beyond the U.S. Workforce Pathways: Sidra Medicine (Qatar Foundation) is rolling out a Medical Observership Programme and continuing its Future Doctor Programme to build clinical education pipelines. Medicaid Enforcement: Indiana is piloting AI with CMS and Oracle to flag Medicaid fraud before payment, while Wisconsin and Arkansas report separate Medicaid fraud arrests and charges. Patient Safety & Care Gaps: A Pennsylvania personal care administrator was sentenced after failing to renew an antiseizure medication, contributing to a resident’s death. Medication Safety in Heat: Health experts warn that summer heat can affect both how people store medicines and how drugs interact with dehydration and sun sensitivity. Reproductive Records Privacy: Illinois Gov. JB Pritzker signed a law shielding abortion and gender dysphoria records from out-of-state sharing. Air Travel Medical Emergency: An Air Canada flight from Newark to Halifax was diverted to Boston after the captain experienced a medical issue; the aircraft landed safely.

Mobile Screening Access: WVU Medicine’s LUCAS mobile lung cancer unit will bring low-dose CT scans to West Virginia sites in July, with appointments needed in advance and coverage via private insurance, Medicaid, or Medicare (grants for eligible uninsured). Nuclear Medicine Quality Boost: Hamad Medical Corporation in Qatar earned SNMMI accreditation as a Radiopharmaceutical Therapy Centre of Excellence, placing it among early non-US recipients. AI Misuse Pushback: The AMA is urging Congress to pass the NO FAKES Act after a Senate Judiciary panel advanced it, aiming to curb AI voice/likeness impersonation and health misinformation. Public Health Preparedness: WHO prepositioned emergency medical supplies across Pakistan ahead of monsoon season, including medicines, water purification tablets, and lab materials for outbreak response. Medication Safety at Home: Hong Kong’s Mannings expanded its Safe Disposal of Unused Medicines program to 75 collection points, offering free drop-off for leftover pills. Fraud Crackdown: U.S. DOJ’s 2026 National Health Care Fraud Takedown charged 455 defendants tied to $6.5B in alleged false claims, including multiple Medicaid cases. Pharma Pipeline Updates: Imbria Pharmaceuticals received FDA orphan drug designation for ninerafaxstat in symptomatic non-obstructive hypertrophic cardiomyopathy, and Helus Pharma reported Phase 3 enrollment for its MDD program surpassing 86%.

Medicaid Fraud Crackdown: A mother-daughter team in San Diego was indicted for allegedly billing Medicare millions for wound care while the nurse practitioner was in federal prison, part of a broader DOJ takedown. More Fraud Charges: Federal prosecutors also charged a New York pair tied to a Medicaid transportation scheme, alleging “ghost rides” and inflated claims. State Oversight: Florida launched a civil investigation into CVS/Caremark, probing whether PBM practices unfairly disadvantage independent pharmacies. Pharmacy Access Expansion: Alaska lawmakers overrode a veto to expand pharmacists’ ability to treat routine conditions like UTIs and strep, with rollout set for 2027. AI in Care Delivery: Munson Medical Center is deploying AI mainly for administrative work and record management, with safety safeguards emphasized. Drug Supply Update: New Zealand’s Pharmac will fund an additional methylphenidate brand (Rubifen LA), but availability is delayed to October 2026 due to supply constraints. Public Health Relief: Michigan will erase $74M in medical debt for nearly 72,000 residents in a second round of relief. Clinical Trial News: Amylyx presented early Phase 1 LUMINA safety data for AMX0114 in ALS at ENCALS 2026. FDA Recall: FDA recalled 11,460 bottles of chlorthalidone after failed dissolution testing, raising concerns about effectiveness.